Isoindolinone compounds as GPR119 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders

• 收藏
• 分享

专利权人:

SANOFI

发明人:

Lothar Schwink,Christian Buning,Heiner Glombik,Matthias Gossel,Dieter Kadereit,Nis Halland,Matthias Lohmann,Christoph Pöverlein,Kurt Ritter

申请号：

US15284334

公开号：

US09908868B2

申请日:

2016.10.03

申请国别(地区):

US

年份:

2018

代理人:

摘要：

The present invention relates to isoindolinone compounds. The isoindolinone compounds are GPR119 modulators and useful for the prevention and/or treatment of diabetes, obesity, dyslipidemia and related disorders. The invention furthermore relates to the use of isoindolinone compounds as active ingredients in pharmaceuticals, and pharmaceutical compositions comprising them.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/